FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Show other versions (1)
Bibliographic Details
Main Authors: Couillard, S, Shrimanker, R, Chaudhuri, R, Mansur, A, McGarvey, L, Heaney, L, Fowler, S, Bradding, P, Pavord, I, Hinks, T
Format: Journal article
Language:English
Published: American Thoracic Society 2021

Similar Items